查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2068764

人工智慧遠距離診斷市場預測至2034年：全球組件、技術、設備類型、連接方式、應用、最終用戶和區域分析

AI-Based Remote Diagnostics Market Forecasts to 2034 - Global Analysis By Component (Software, Hardware, and Services), Technology, Device Type, Connectivity, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球人工智慧驅動的遠距離診斷市場預計將在 2026 年達到 58 億美元，到 2034 年達到 224 億美元，在預測期內以 18.4% 的複合年成長率成長。

人工智慧遠距離診斷是指一系列利用人工智慧、循環系統學習和電腦視覺技術，在傳統醫院環境之外對患者進行臨床評估的解決方案。這些平台分析來自穿戴式感測器、攜帶式裝置和連網裝置的數據，以識別心臟病學、放射學、腫瘤學和其他專科領域的病理模式。透過自動化影像解讀、異常檢測和預測風險評分，這些系統將診斷能力擴展到醫療資源匱乏的地區，實現疾病的早期發現，並減輕已開發國家和開發中國家醫療機構中過度勞累的臨床醫生的診斷負擔。

對便捷、及時的診斷服務的需求激增。

全球醫療系統，尤其是放射科和病理科，正面臨診斷需求與臨床能力之間日益擴大的差距這項挑戰。人工智慧驅動的遠距離診斷平台透過自動化影像解讀和分診流程來應對這項挑戰，使一位專家能夠診治更多患者。先前難以獲得專科診斷的農村和醫療資源匱乏地區的人們，如今也能受益於人工智慧輔助的篩檢。已採用這些工具的醫療機構報告稱，診斷時間縮短、漏診率降低、患者處理能力提升，這使得人工智慧驅動的遠距離診斷對於預算緊張、尋求提高效率的醫療系統而言，成為極具吸引力的價值提案。

演算法偏差和缺乏多樣化的訓練資料集

許多人工智慧診斷演算法的開發都使用了過度偏向特定種族、年齡層或特定影像設備類型的資料集，導致其在不同患者群體中的表現差異很大。監管機構和醫院採購委員會在批准臨床應用之前，越來越重視演算法的公平性，加重了檢驗的負擔。如果發現人工智慧工具在特定族群中靈敏度或特異性較低，醫療機構將面臨法律責任風險。解決這些偏差需要大量投資來開發具有代表性的資料集和重新訓練模型，這實際上構成了准入門檻，並減緩了其廣泛的商業性應用。

與 5G 連接和邊緣運算基礎設施整合

全球5G無線網路的部署，以及邊緣運算技術的進步，正在為基於人工智慧的遠距離診斷打造理想的基礎設施。低延遲的5G通訊將能夠把高解析度診斷影像從現場行動裝置、救護車和鄉村診所即時傳輸到人工智慧分析引擎。邊緣人工智慧處理減少了對集中式雲端連接的依賴，這在寬頻存取不穩定的地區至關重要。隨著新興經濟體通訊基礎設施投資的加速成長，此前難以觸及的地區對即時人工智慧診斷的潛在市場正在以驚人的速度擴張。

醫生對人工智慧診斷的抵觸情緒以及相關的法律責任框架。

人工智慧遠距離診斷的臨床應用面臨來自醫生的文化阻力，他們擔心過度依賴演算法輸出，導致診斷自主性下降。大多數司法管轄區的醫療法律框架仍然缺乏明確的責任界定，尤其是在人工智慧系統產生錯誤觀察並影響臨床決策的情況下。醫院不願採用責任不明的工具。由於缺乏針對人工智慧作為臨床決策支援工具和作為自主診斷設備的明確監管指南，法律審查常常導致採購決策延誤，儘管受控檢驗研究已證明其具有很高的技術性能，但市場滲透率仍然較低。

新型冠狀病毒（COVID-19）的影響：

新冠疫情大大推動了人工智慧遠距離診斷的發展，醫療系統迅速採用人工智慧驅動的乳房攝影篩檢影像工具，用於疑似病例分診和肺炎模式識別。美國食品藥物管理局（FDA）和歐盟CE認證機構緊急批准了人工智慧診斷工具，為加快核准流程樹立了先例。疫情過後，人工智慧診斷正更深入地融入放射科和病理科的常規工作流程，醫院維持或擴大了疫情期間的投資，使市場在最初的緊急應用階段之後保持了持續成長勢頭。

在預測期內，軟體領域預計將佔據最大佔有率。

人工智慧診斷平台、臨床決策支援系統和分析工具構成了該市場價值創造的核心，預計軟體領域在預測期內將佔據最大的市場佔有率。軟體解決方案透過訂閱和按次付費授權模式產生持續收入，與硬體相比，為供應商提供了極具吸引力的單位盈利。從放射學人工智慧到病理影像分析，軟體可應用於廣泛的臨床領域，確保了各學科的持續需求。領先的科技公司和醫療系統持續投資於自主軟體的開發和第三方平台的整合，進一步鞏固了該領域在收入方面的主導地位。

預計在預測期內，邊緣人工智慧領域將呈現最高的複合年成長率。

在預測期內，邊緣人工智慧領域預計將呈現最高的成長率，這主要得益於在通訊不穩定的環境下對低延遲診斷處理的迫切需求。邊緣人工智慧能夠將推理模型直接部署在攜帶式診斷設備上，因此無需依賴雲端即可進行即時分析。這種架構在軍事醫療、現場分診和新興市場的本地診斷領域尤其重要。半導體技術的進步使得在小型晶片上實現強大的人工智慧推理能力成為可能，加上邊緣部署模型臨床有效性的持續檢驗，正在推動大量的研發投入，並加速所有主要設備類別的商業化進程。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率。這主要得益於北美地區人工智慧醫療技術創新者密集的生態系統、美國國立食品藥物管理局研究院 (NIH) 和創業投資的大量研究經費，以及美國食品藥物管理局 (FDA) 數位健康卓越中心建立的寬鬆法規環境。美國醫療保健系統正積極將人工智慧診斷技術整合到放射學、病理學和循環系統的工作流程中，這主要得益於臨床實踐處方 (CPT) 計費代碼在某些成像模式下應用於人工智慧輔助影像解讀。加拿大對全國醫療保健數據平台的投資進一步推動了該地區的成長，鞏固了北美在整個預測期內作為最大收入來源地區的地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、印度、日本和韓國政府主導的數位化醫療轉型計畫。中國在人工智慧領域的大規模國內投資正在打造具有競爭力的自主研發人工智慧診斷平台。同時，印度的遠端醫療政策改革為農村醫療中心提供了遠距離診斷工具的巨大潛在市場。該地區龐大的人口深受慢性病困擾，加上大都會圈專家嚴重短缺，為可擴展的人工智慧診斷技術的應用創造了結構性有利的需求條件。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球人工智慧遠距離診斷市場：按組件分類

  • 軟體
    • 診斷平台
    • 人工智慧演算法和分析工具
    • 臨床決策支援系統
  • 硬體
    • 穿戴式診斷設備
    • 遠端監控設備
    • 智慧感測器
  • 服務
    • 諮詢服務
    • 整合與部署
    • 維護和支援

第6章：全球人工智慧遠距離診斷市場：按技術分類

  • 機器學習
  • 深度學習
  • 自然語言處理（NLP）
  • 電腦視覺
  • 預測分析
  • 邊緣人工智慧

第7章：全球人工智慧遠距離診斷市場：按設備類型分類

  • 智慧型手機和平板電腦
  • 穿戴式裝置
  • 攜帶式診斷設備
  • 連網醫療設備
  • 物聯網監控系統

第8章：全球人工智慧遠距離診斷市場：連結性與性別

  • Bluetooth
  • Wi-Fi
  • 蜂巢式網路
  • 5G連接
  • 衛星通訊

第9章：全球人工智慧遠距離診斷市場：按應用分類

  • 循環系統診斷
  • 放射診斷
  • 神經學診斷
  • 腫瘤診斷
  • 呼吸系統疾病的診斷
  • 糖尿病管理與診斷
  • 感染疾病診斷
  • 皮膚病診斷
  • 病理診斷

第10章：全球人工智慧遠距離診斷市場：按最終用戶分類

  • 醫院和診所
  • 診斷中心
  • 家庭醫療保健服務提供者
  • 門診手術中心
  • 研究機構
  • 遠端醫療提供者

第11章：全球人工智慧遠距離診斷市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Siemens Healthineers
  • GE HealthCare
  • Philips
  • Medtronic
  • IBM
  • Microsoft
  • Google Health
  • NVIDIA
  • Aidoc
  • Qure.ai
  • Viz.ai
  • AliveCor
  • Butterfly Network
  • Tempus AI
  • PathAI
Product Code: SMRC37047

According to Stratistics MRC, the Global AI-Based Remote Diagnostics Market is accounted for $5.8 billion in 2026 and is expected to reach $22.4 billion by 2034, growing at a CAGR of 18.4% during the forecast period. AI-Based Remote Diagnostics encompasses a suite of technology solutions that leverage artificial intelligence, machine learning, and computer vision to perform clinical assessments of patients outside traditional hospital settings. These platforms analyze data from wearable sensors, portable devices, and connected equipment to identify pathological patterns across cardiology, radiology, oncology, and other specialties. By automating image interpretation, anomaly detection, and predictive risk scoring, these systems extend diagnostic capabilities to underserved geographies, enable earlier disease detection, and reduce the diagnostic burden on overstretched clinical professionals in both developed and developing healthcare environments.

Market Dynamics:

Driver:

Surging demand for accessible and timely diagnostic services

Healthcare systems worldwide face a widening gap between diagnostic demand and clinical capacity, particularly in radiology and pathology. AI-based remote diagnostic platforms address this challenge by automating image interpretation and triage workflows, allowing a single specialist to oversee vastly greater patient volumes. Rural and underserved populations that previously lacked access to specialist diagnostics can now benefit from AI-enabled screening. Healthcare providers adopting these tools report shorter diagnostic turnaround times, fewer missed findings, and improved patient throughput making AI remote diagnostics a compelling value proposition for cost-constrained systems seeking efficiency gains.

Restraint:

Algorithmic bias and lack of diverse training datasets

Many AI diagnostic algorithms have been developed using datasets that overrepresent specific ethnic groups, age ranges, and imaging equipment types, resulting in variable performance across different patient populations. Regulators and hospital procurement committees are increasingly scrutinizing algorithmic fairness before approving clinical deployment, adding validation burden. When AI tools demonstrate lower sensitivity or specificity in certain demographic cohorts, liability concerns arise for healthcare providers. Addressing these biases requires substantial investment in representative dataset curation and model retraining programs, creating a meaningful entry barrier that slows broad commercial adoption.

Opportunity:

Integration with 5G connectivity and edge computing infrastructure

The global rollout of 5G wireless networks, combined with advances in edge computing, is creating infrastructure conditions ideally suited to AI-based remote diagnostics. Low-latency 5G transmission enables real-time streaming of high-resolution diagnostic images from portable devices in field settings, ambulances, and rural clinics to AI analysis engines. Edge AI processing reduces dependence on centralized cloud connectivity, critical for regions with inconsistent broadband access. As telecommunications infrastructure investment accelerates across emerging economies, the addressable market for real-time AI diagnostics in previously unreachable geographies is expanding at a compelling rate.

Threat:

Physician resistance and liability frameworks for AI-generated findings

Clinical adoption of AI remote diagnostics faces cultural resistance from physicians concerned about over-reliance on algorithmic outputs and the erosion of diagnostic autonomy. Medico-legal frameworks in most jurisdictions have yet to clearly define liability when an AI system produces an erroneous finding that influences clinical decision-making. Hospitals are hesitant to deploy tools where accountability remains ambiguous. Without clear regulatory guidance on AI as a clinical decision support tool versus an autonomous diagnostic device, procurement decisions are often delayed by legal reviews, slowing market penetration despite strong technical performance demonstrated in controlled validation studies.

Covid-19 Impact:

The COVID-19 pandemic served as a powerful catalyst for AI-based remote diagnostics, with health systems rapidly deploying AI chest imaging tools to triage suspected cases and identify pneumonia patterns. Emergency regulatory approvals for AI diagnostic tools were issued by the FDA and CE mark authorities, establishing precedent for accelerated review pathways. Post-pandemic, the integration of AI diagnostics into standard radiology and pathology workflows has deepened, with hospitals maintaining or expanding investments made during the crisis period, providing durable momentum for the market beyond the initial emergency deployment phase.

The Software segment is expected to be the largest during the forecast period

The Software segment is expected to account for the largest market share during the forecast period, as AI diagnostic platforms, clinical decision support systems, and analytics tools represent the intellectual core of value creation in this market. Software solutions generate recurring revenue through subscription and per-study licensing models, offering vendors attractive unit economics relative to hardware. The breadth of clinical applications addressable through software from radiology AI to pathology image analysis-ensures consistent cross-specialty demand. Continued investment by major technology companies and health systems in proprietary software development and third-party platform integration further cements this segment's leading revenue position.

The Edge AI segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Edge AI segment is predicted to witness the highest growth rate, driven by the critical need for low-latency diagnostic processing in settings with unreliable connectivity. Edge AI deploys inference models directly on portable diagnostic devices, enabling real-time analysis without cloud dependency. This architecture is particularly valuable in military medicine, field triage, and rural diagnostics in emerging markets. Semiconductor advances enabling powerful AI inference on compact chips, combined with growing clinical validation of edge-deployed models, are attracting significant R&D investment and accelerating commercialization timelines across all major device categories.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, anchored by a dense ecosystem of AI health technology innovators, significant NIH and venture capital research funding, and a receptive regulatory environment under the FDA's Digital Health Center of Excellence. United States healthcare systems are actively integrating AI diagnostics into radiology, pathology, and cardiology workflows, supported by CPT billing codes for AI-assisted interpretation in select modalities. Canada's investment in national health data platforms further supports regional growth, consolidating North America's position as the leading revenue-generating geography through the forecast horizon.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, energized by government-mandated digital health transformation programs in China, India, Japan, and South Korea. China's substantial domestic AI investment has produced competitive indigenous diagnostic AI platforms, while India's telemedicine policy reforms are creating a large addressable market for affordable remote diagnostic tools in rural health centers. The region's vast populations with high chronic disease burdens, combined with acute specialist shortages in non-metropolitan areas, create structural demand conditions highly favorable to scalable AI diagnostic deployment.

Key players in the market

Some of the key players in AI-Based Remote Diagnostics Market include Siemens Healthineers, GE HealthCare, Philips, Medtronic, IBM, Microsoft, Google Health, NVIDIA, Aidoc, Qure.ai, Viz.ai, AliveCor, Butterfly Network, Tempus AI, PathAI.

Key Developments:

In April 2026, Qure.ai secured a large-scale deployment contract with a South Asian national health authority to integrate its chest X-ray AI platform across primary health centers in underserved districts, targeting early detection of tuberculosis and respiratory diseases in a population with limited specialist radiology access.

In February 2026, Siemens Healthineers announced the regulatory clearance of its AI-Rad Companion Chest CT module for pneumothorax detection in the United States, enabling automated triage of chest imaging studies and prioritizing urgent findings for radiologist review in high-volume diagnostic departments.

Components Covered:

  • Software
  • Hardware
  • Services

Technologies Covered:

  • Machine Learning
  • Deep Learning
  • NLP
  • Computer Vision
  • Predictive Analytics
  • Edge AI

Device Types Covered:

  • Smartphones & Tablets
  • Wearable Devices
  • Portable Diagnostic Devices
  • Connected Medical Devices
  • IoT-Enabled Monitoring Systems

Connectivities Covered:

  • Bluetooth
  • Wi-Fi
  • Cellular Networks
  • 5G Connectivity
  • Satellite Connectivity

Applications Covered:

  • Cardiology
  • Radiology
  • Neurology
  • Oncology
  • Respiratory
  • Diabetes Management
  • Infectious Disease
  • Dermatology
  • Pathology Diagnostics

End Users Covered:

  • Hospitals & Clinics
  • Diagnostic Centers
  • Home Healthcare Providers
  • Ambulatory Surgical Centers
  • Research Institutes
  • Telemedicine Providers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Qatar
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Morocco
      • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global AI-Based Remote Diagnostics Market, By Component

  • 5.1 Software
    • 5.1.1 Diagnostic Platforms
    • 5.1.2 AI Algorithms & Analytics Tools
    • 5.1.3 Clinical Decision Support Systems
  • 5.2 Hardware
    • 5.2.1 Wearable Diagnostic Devices
    • 5.2.2 Remote Monitoring Equipment
    • 5.2.3 Smart Sensors
  • 5.3 Services
    • 5.3.1 Consulting Services
    • 5.3.2 Integration & Deployment
    • 5.3.3 Maintenance & Support

6 Global AI-Based Remote Diagnostics Market, By Technology

  • 6.1 Machine Learning
  • 6.2 Deep Learning
  • 6.3 Natural Language Processing (NLP)
  • 6.4 Computer Vision
  • 6.5 Predictive Analytics
  • 6.6 Edge AI

7 Global AI-Based Remote Diagnostics Market, By Device Type

  • 7.1 Smartphones & Tablets
  • 7.2 Wearable Devices
  • 7.3 Portable Diagnostic Devices
  • 7.4 Connected Medical Devices
  • 7.5 IoT-Enabled Monitoring Systems

8 Global AI-Based Remote Diagnostics Market, By Connectivity

  • 8.1 Bluetooth
  • 8.2 Wi-Fi
  • 8.3 Cellular Networks
  • 8.4 5G Connectivity
  • 8.5 Satellite Connectivity

9 Global AI-Based Remote Diagnostics Market, By Application

  • 9.1 Cardiology Diagnostics
  • 9.2 Radiology Diagnostics
  • 9.3 Neurology Diagnostics
  • 9.4 Oncology Diagnostics
  • 9.5 Respiratory Disease Diagnostics
  • 9.6 Diabetes Management Diagnostics
  • 9.7 Infectious Disease Diagnostics
  • 9.8 Dermatology Diagnostics
  • 9.9 Pathology Diagnostics

10 Global AI-Based Remote Diagnostics Market, By End User

  • 10.1 Hospitals & Clinics
  • 10.2 Diagnostic Centers
  • 10.3 Home Healthcare Providers
  • 10.4 Ambulatory Surgical Centers
  • 10.5 Research Institutes
  • 10.6 Telemedicine Providers

11 Global AI-Based Remote Diagnostics Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Siemens Healthineers
  • 14.2 GE HealthCare
  • 14.3 Philips
  • 14.4 Medtronic
  • 14.5 IBM
  • 14.6 Microsoft
  • 14.7 Google Health
  • 14.8 NVIDIA
  • 14.9 Aidoc
  • 14.10 Qure.ai
  • 14.11 Viz.ai
  • 14.12 AliveCor
  • 14.13 Butterfly Network
  • 14.14 Tempus AI
  • 14.15 PathAI

List of Tables

  • Table 1 Global AI-Based Remote Diagnostics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global AI-Based Remote Diagnostics Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global AI-Based Remote Diagnostics Market Outlook, By Software (2023-2034) ($MN)
  • Table 4 Global AI-Based Remote Diagnostics Market Outlook, By Diagnostic Platforms (2023-2034) ($MN)
  • Table 5 Global AI-Based Remote Diagnostics Market Outlook, By AI Algorithms & Analytics Tools (2023-2034) ($MN)
  • Table 6 Global AI-Based Remote Diagnostics Market Outlook, By Clinical Decision Support Systems (2023-2034) ($MN)
  • Table 7 Global AI-Based Remote Diagnostics Market Outlook, By Hardware (2023-2034) ($MN)
  • Table 8 Global AI-Based Remote Diagnostics Market Outlook, By Wearable Diagnostic Devices (2023-2034) ($MN)
  • Table 9 Global AI-Based Remote Diagnostics Market Outlook, By Remote Monitoring Equipment (2023-2034) ($MN)
  • Table 10 Global AI-Based Remote Diagnostics Market Outlook, By Smart Sensors (2023-2034) ($MN)
  • Table 11 Global AI-Based Remote Diagnostics Market Outlook, By Services (2023-2034) ($MN)
  • Table 12 Global AI-Based Remote Diagnostics Market Outlook, By Consulting Services (2023-2034) ($MN)
  • Table 13 Global AI-Based Remote Diagnostics Market Outlook, By Integration & Deployment (2023-2034) ($MN)
  • Table 14 Global AI-Based Remote Diagnostics Market Outlook, By Maintenance & Support (2023-2034) ($MN)
  • Table 15 Global AI-Based Remote Diagnostics Market Outlook, By Technology (2023-2034) ($MN)
  • Table 16 Global AI-Based Remote Diagnostics Market Outlook, By Machine Learning (2023-2034) ($MN)
  • Table 17 Global AI-Based Remote Diagnostics Market Outlook, By Deep Learning (2023-2034) ($MN)
  • Table 18 Global AI-Based Remote Diagnostics Market Outlook, By Natural Language Processing (NLP) (2023-2034) ($MN)
  • Table 19 Global AI-Based Remote Diagnostics Market Outlook, By Computer Vision (2023-2034) ($MN)
  • Table 20 Global AI-Based Remote Diagnostics Market Outlook, By Predictive Analytics (2023-2034) ($MN)
  • Table 21 Global AI-Based Remote Diagnostics Market Outlook, By Edge AI (2023-2034) ($MN)
  • Table 22 Global AI-Based Remote Diagnostics Market Outlook, By Device Type (2023-2034) ($MN)
  • Table 23 Global AI-Based Remote Diagnostics Market Outlook, By Smartphones & Tablets (2023-2034) ($MN)
  • Table 24 Global AI-Based Remote Diagnostics Market Outlook, By Wearable Devices (2023-2034) ($MN)
  • Table 25 Global AI-Based Remote Diagnostics Market Outlook, By Portable Diagnostic Devices (2023-2034) ($MN)
  • Table 26 Global AI-Based Remote Diagnostics Market Outlook, By Connected Medical Devices (2023-2034) ($MN)
  • Table 27 Global AI-Based Remote Diagnostics Market Outlook, By IoT-Enabled Monitoring Systems (2023-2034) ($MN)
  • Table 28 Global AI-Based Remote Diagnostics Market Outlook, By Connectivity (2023-2034) ($MN)
  • Table 29 Global AI-Based Remote Diagnostics Market Outlook, By Bluetooth (2023-2034) ($MN)
  • Table 30 Global AI-Based Remote Diagnostics Market Outlook, By Wi-Fi (2023-2034) ($MN)
  • Table 31 Global AI-Based Remote Diagnostics Market Outlook, By Cellular Networks (2023-2034) ($MN)
  • Table 32 Global AI-Based Remote Diagnostics Market Outlook, By 5G Connectivity (2023-2034) ($MN)
  • Table 33 Global AI-Based Remote Diagnostics Market Outlook, By Satellite Connectivity (2023-2034) ($MN)
  • Table 34 Global AI-Based Remote Diagnostics Market Outlook, By Application (2023-2034) ($MN)
  • Table 35 Global AI-Based Remote Diagnostics Market Outlook, By Cardiology Diagnostics (2023-2034) ($MN)
  • Table 36 Global AI-Based Remote Diagnostics Market Outlook, By Radiology Diagnostics (2023-2034) ($MN)
  • Table 37 Global AI-Based Remote Diagnostics Market Outlook, By Neurology Diagnostics (2023-2034) ($MN)
  • Table 38 Global AI-Based Remote Diagnostics Market Outlook, By Oncology Diagnostics (2023-2034) ($MN)
  • Table 39 Global AI-Based Remote Diagnostics Market Outlook, By Respiratory Disease Diagnostics (2023-2034) ($MN)
  • Table 40 Global AI-Based Remote Diagnostics Market Outlook, By Diabetes Management Diagnostics (2023-2034) ($MN)
  • Table 41 Global AI-Based Remote Diagnostics Market Outlook, By Infectious Disease Diagnostics (2023-2034) ($MN)
  • Table 42 Global AI-Based Remote Diagnostics Market Outlook, By Dermatology Diagnostics (2023-2034) ($MN)
  • Table 43 Global AI-Based Remote Diagnostics Market Outlook, By Pathology Diagnostics (2023-2034) ($MN)
  • Table 44 Global AI-Based Remote Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 45 Global AI-Based Remote Diagnostics Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 46 Global AI-Based Remote Diagnostics Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 47 Global AI-Based Remote Diagnostics Market Outlook, By Home Healthcare Providers (2023-2034) ($MN)
  • Table 48 Global AI-Based Remote Diagnostics Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 49 Global AI-Based Remote Diagnostics Market Outlook, By Research Institutes (2023-2034) ($MN)
  • Table 50 Global AI-Based Remote Diagnostics Market Outlook, By Telemedicine Providers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.